COMPANY

Maxwell Biomedical

HQ: San Diego, CA source · maxwellbiomedical.com ↗ · West Coast

We developed a physiologically realistic computer model of AF that lets researchers define regions of anisotropic conduction and test treatment strategies in a live simulation. From company website Source · Oct 12, 2026

Keywords: Atrial Fibrillation

Location: San Diego, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)3NIH grants

Timeline

Jun 23, 2022 Trial start Not phased (device or behavioral study): Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT05461612	Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation	Not phased (device or behavioral study)	Unknown status (ClinicalTrials.gov)	Jun 23, 2022	2023-06 (estimated)

NIH awards 3

Annual award amounts. Total $2.3M.

Aug 6, 2025 NIH award 5R44HL164195-03 FY2025: $1,247,262 awarded for that fiscal year; activity R44 (SBIR); PI WERNETH, RANDY; recipient as written: MAXWELL BIOMEDICAL INC, SAN DIEGO, CA. Spatial Resynchronization Therapy for AF source ↗
Jul 19, 2024 NIH award 2R44HL164195-02 FY2024: $749,419 awarded for that fiscal year; activity R44 (SBIR); PI BEATTY, GRAYDON ERNEST; recipient as written: MAXWELL BIOMEDICAL INC, SAN DIEGO, CA. Spatial Resynchronization Therapy source ↗
Sep 15, 2022 NIH award 1R43HL164195-01A1 FY2022: $299,449 awarded for that fiscal year; activity R43 (SBIR); PI BEATTY, GRAYDON ERNEST; recipient as written: MAXWELL BIOMEDICAL INC, SAN DIEGO, CA. Spatial Resynchronization Therap source ↗